Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differences.
Saved in:
| Title: | Leveraging multiomic approaches to elucidate mechanisms of heterogeneity in Alzheimer's disease: Neuropsychiatric symptoms, co-pathologies, and sex differences. |
|---|---|
| Authors: | Shwab EK; Division of Translational Brain Sciences, Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.; Center for Genomic and Computational Biology, Duke University Medical Center, Durham, North Carolina, USA., Pathak GA; Institute for Genomic Health, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Harvey J; Department of Clinical and Biomedical Sciences, University of Exeter Medical School, University of Exeter, Exeter, UK., Belloy ME; Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.; Neurogenomics and Informatics Center, Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA., Fischer CE; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada., Lutz MW; Division of Translational Brain Sciences, Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA., Scholz SW; Neurodegenerative Diseases Research Section, National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, USA.; Department of Neurology, Johns Hopkins University Medical Center, Baltimore, Maryland, USA., Cook N; Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.; Neurogenomics and Informatics Center, Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA., Reid DM; Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, USA.; Neurogenomics and Informatics Center, Washington University in St. Louis, School of Medicine, St. Louis, Missouri, USA., Chen J; Nevada Institute of Personalized Medicine, University of Nevada, Las Vegas, Nevada, USA.; School of Life Science, University of Nevada, Las Vegas, Nevada, USA.; Interdisciplinary Neuroscience Program, University of Nevada, Las Vegas, Nevada, USA., Guan DX; Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Oliveira F; Department of Neurology and Neurosurgery, Escola Paulista de Medicina, Federal University of São Paulo (UNIFESP), São Paulo, Brazil., Sinclair LI; Translational Dementia Research Group, Faculty of Health Sciences, University of Bristol, Southmead Hospital, Bristol, UK., Imo U; College of Medicine, University of Ibadan, Oyo, Nigeria., Creese B; Department of Psychology, College of Health Medicine and Life Sciences, Brunel University of London, London, UK., Chiba-Falek O; Division of Translational Brain Sciences, Department of Neurology, Duke University Medical Center, Durham, North Carolina, USA.; Center for Genomic and Computational Biology, Duke University Medical Center, Durham, North Carolina, USA. |
| Corporate Authors: | Neuropsychiatric Syndromes Professional Interest Area Multiomics Work Group, Alzheimer's Association, International Society to Advance Alzheimer's Research and Treatment, Chicago, Illinois, USA |
| Source: | Alzheimer's & dementia : the journal of the Alzheimer's Association [Alzheimers Dement] 2025 Aug; Vol. 21 (8), pp. e70549. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: John Wiley & Sons, Ltd Country of Publication: United States NLM ID: 101231978 Publication Model: Print Cited Medium: Internet ISSN: 1552-5279 (Electronic) Linking ISSN: 15525260 NLM ISO Abbreviation: Alzheimers Dement Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1552-5279 |
|---|---|
| DOI: | 10.1002/alz.70549 |
